3.2.1.33	1,4-diaminobutane	putrescine, glycogen debranching enzyme, slight inhibition	1296	
3.2.1.33	1-deoxynojirimycin	-	557	
3.2.1.33	1-deoxynojirimycin	in primary rat hepatocytes, the inhibition of glycogen breakdown reaches plateau at 100 microM with 25% inhibition and then remains unchanged	557	
3.2.1.33	1-S-dimethylarsino-1-thio-beta-D-glucanopyranoside	DATG, active site-directed irreversible inhibitor, inhibition: mechanism. Inactivation occurs with significant conformational change	31730	
3.2.1.33	1-S-dimethylarsino-1-thio-beta-D-glucanopyranoside	DATG, active site-directed irreversible inhibitor, inhibition: mechanism. Inactivation occurs with significant conformational change; glycogen phosphorylase limit dextrin and Bis-Tris protect from inactivation	31730	
3.2.1.33	2,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol	Bis-Tris, reversible inhibitor	13024	
3.2.1.33	2,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol	10 mM: 97% inhibition; Bis-Tris, reversible inhibitor	13024	
3.2.1.33	2,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol	Bis-Tris, reversible inhibitor; noncompetitive with glycogen phosphorylase limit dextrin, competitive with glucose	13024	
3.2.1.33	2,2-bis(hydroxymethyl)-2,2',2''-nitrilotriethanol	-	13024	
3.2.1.33	2-(2-hydroxyethylamino)-2-hydroxymethyl-1,3-propanediol	hydroxyethyltris	101804